Biogen shares fall after it scraps Alzheimer's treatment

In this video

Share

Biogen shares fall after it scraps Alzheimer's treatment

Biogen shares tumble after the drug maker discontinued late-stage trials of an Alzheimer's treatment.
01:40
Thu, Mar 21 20198:17 AM EDT